Study to Assess the Effect of Consumption of Fish Oil Encapsulated on Inflammatory Markers in Colorectal Cancer

NCT01575340 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 11

Last updated 2012-09-06

No results posted yet for this study

Summary

The purpose of this study is to evaluate whether supplementation 2g/day encapsulated fish oil modifies inflammatory markers in individuals with colorectal cancer in chemotherapy

Conditions

Interventions

DIETARY_SUPPLEMENT

fish oil encapsuled

2 g/d (4 capsules of 500 mg)for 9 weeks

Sponsors & Collaborators

  • Fundação de Amparo à Pesquisa e a Inovação do Estado de Santa Catarina

    collaborator UNKNOWN
  • Centro de Pesquisas Oncológicas de Florianópolis

    collaborator UNKNOWN
  • Universidade Federal de Santa Catarina

    lead OTHER

Principal Investigators

  • Michel C Mocellin, Master's · Universidade Federal de Santa Catarina

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-07-31
Primary Completion
2012-05-31
Completion
2012-07-31

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01575340 on ClinicalTrials.gov